Annual CFI
$16.35 M
-$37.02 M-69.37%
31 December 2023
Summary:
Black Diamond Therapeutics annual cash flow from investing activities is currently $16.35 million, with the most recent change of -$37.02 million (-69.37%) on 31 December 2023. During the last 3 years, it has risen by +$298.04 million (+105.80%). BDTX annual CFI is now -87.49% below its all-time high of $130.61 million, reached on 31 December 2021.BDTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$2.19 M
+$1.45 M+196.35%
30 September 2024
Summary:
Black Diamond Therapeutics quarterly cash flow from investing activities is currently $2.19 million, with the most recent change of +$1.45 million (+196.35%) on 30 September 2024. Over the past year, it has increased by +$40.08 million (+105.79%). BDTX quarterly CFI is now -95.45% below its all-time high of $48.20 million, reached on 30 June 2021.BDTX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$1.45 M
+$40.08 M+103.75%
30 September 2024
Summary:
Black Diamond Therapeutics TTM cash flow from investing activities is currently $1.45 million, with the most recent change of +$40.08 million (+103.75%) on 30 September 2024. Over the past year, it has dropped by -$4.97 million (-77.44%). BDTX TTM CFI is now -98.99% below its all-time high of $143.87 million, reached on 31 March 2022.BDTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDTX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -69.4% | +105.8% | -77.4% |
| 3 y3 years | +105.8% | -93.9% | -98.2% |
| 5 y5 years | +10000.0% | +10000.0% | +7721.1% |
BDTX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -87.5% | +105.8% | -94.9% | +105.8% | -99.0% | +103.8% |
| 5 y | 5 years | -87.5% | +105.8% | -95.5% | +100.8% | -99.0% | +100.5% |
| alltime | all time | -87.5% | +105.8% | -95.5% | +100.8% | -99.0% | +100.5% |
Black Diamond Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.19 M(+196.4%) | $1.45 M(-103.7%) |
| June 2024 | - | $740.00 K(-105.4%) | -$38.63 M(+74.1%) |
| Mar 2024 | - | -$13.73 M(-212.1%) | -$22.19 M(-235.8%) |
| Dec 2023 | $16.35 M(-69.4%) | $12.25 M(-132.3%) | $16.35 M(+154.7%) |
| Sept 2023 | - | -$37.88 M(-320.6%) | $6.42 M(-89.1%) |
| June 2023 | - | $17.18 M(-30.8%) | $58.81 M(-4.3%) |
| Mar 2023 | - | $24.81 M(+968.3%) | $61.44 M(+15.1%) |
| Dec 2022 | $53.37 M(-59.1%) | $2.32 M(-84.0%) | $53.37 M(-43.4%) |
| Sept 2022 | - | $14.51 M(-26.8%) | $94.29 M(-18.4%) |
| June 2022 | - | $19.81 M(+18.4%) | $115.48 M(-19.7%) |
| Mar 2022 | - | $16.73 M(-61.3%) | $143.87 M(+10.1%) |
| Dec 2021 | $130.61 M | $43.24 M(+21.1%) | $130.61 M(+61.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $35.70 M(-25.9%) | $80.72 M(+62.7%) |
| June 2021 | - | $48.20 M(+1287.4%) | $49.62 M(-117.8%) |
| Mar 2021 | - | $3.47 M(-152.3%) | -$278.22 M(-1.2%) |
| Dec 2020 | -$281.69 M(>+9900.0%) | -$6.65 M(-244.6%) | -$281.69 M(+2.4%) |
| Sept 2020 | - | $4.60 M(-101.6%) | -$275.05 M(-1.6%) |
| June 2020 | - | -$279.64 M(<-9900.0%) | -$279.65 M(>+9900.0%) |
| Mar 2020 | - | $0.00(-100.0%) | -$11.00 K(-47.6%) |
| Dec 2019 | -$21.00 K(-72.4%) | -$2000.00(-81.8%) | -$21.00 K(+10.5%) |
| Sept 2019 | - | -$11.00 K(-650.0%) | -$19.00 K(+137.5%) |
| June 2019 | - | $2000.00(-120.0%) | -$8000.00(-20.0%) |
| Mar 2019 | - | -$10.00 K | -$10.00 K |
| Dec 2018 | -$76.00 K(-1.3%) | - | - |
| Dec 2017 | -$77.00 K | - | - |
FAQ
- What is Black Diamond Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual CFI year-on-year change?
- What is Black Diamond Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly CFI year-on-year change?
- What is Black Diamond Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics TTM CFI year-on-year change?
What is Black Diamond Therapeutics annual cash flow from investing activities?
The current annual CFI of BDTX is $16.35 M
What is the all time high annual CFI for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual cash flow from investing activities is $130.61 M
What is Black Diamond Therapeutics annual CFI year-on-year change?
Over the past year, BDTX annual cash flow from investing activities has changed by -$37.02 M (-69.37%)
What is Black Diamond Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of BDTX is $2.19 M
What is the all time high quarterly CFI for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly cash flow from investing activities is $48.20 M
What is Black Diamond Therapeutics quarterly CFI year-on-year change?
Over the past year, BDTX quarterly cash flow from investing activities has changed by +$40.08 M (+105.79%)
What is Black Diamond Therapeutics TTM cash flow from investing activities?
The current TTM CFI of BDTX is $1.45 M
What is the all time high TTM CFI for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high TTM cash flow from investing activities is $143.87 M
What is Black Diamond Therapeutics TTM CFI year-on-year change?
Over the past year, BDTX TTM cash flow from investing activities has changed by -$4.97 M (-77.44%)